Xencor (XNCR) Earnings Date & Reports

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

XNCR is expected to report earnings to fall 53.09% to -80 cents per share on August 05

Q2'26

Est.

$-0.80

Q1'26

Missed

by $1.05

Q4'25

Beat

by $0.51

Q3'25

Beat

by $0.61

Q2'25

Beat

by $0.31

The last earnings report on May 06 showed earnings per share of -171 cents, missing the estimate of -66 cents. With 87.83K shares outstanding, the current market capitalization sits at 1.04B.

View a ticker or compare two or three

Compare

XNCR

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for XNCR